Evidence map›Paper›PMID 37175832›Full record

ArticleInternational journal of molecular sciences2023

Benzoquinoline Derivatives: An Attractive Approach to Newly Small Molecules with Anticancer Activity.

Liliana Oniciuc, Dorina Amăriucăi-Mantu, Dumitrela Diaconu, Violeta Mangalagiu, Ramona Danac, Vasilichia Antoci, Ionel I Mangalagiu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Molecules (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Article
  9. Recent Advances in the Green Synthesis of ActivePharmaceuticals (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Liliana OniciucFaculty of Chemistry, Alexandru Ioan Cuza University of Iasi, 11 Carol 1st Bvd, 700506 Iasi, Romania.
Dorina Amăriucăi-MantuFaculty of Chemistry, Alexandru Ioan Cuza University of Iasi, 11 Carol 1st Bvd, 700506 Iasi, Romania.
Dumitrela DiaconuFaculty of Chemistry, Alexandru Ioan Cuza University of Iasi, 11 Carol 1st Bvd, 700506 Iasi, Romania.ORCID 0000-0001-9157-3995
Violeta MangalagiuInstitute of Interdisciplinary Research-CERNESIM Center, Alexandru Ioan Cuza University of Iasi, 11 Carol I, 700506 Iasi, Romania.ORCID 0000-0002-9768-8686
Ramona DanacFaculty of Chemistry, Alexandru Ioan Cuza University of Iasi, 11 Carol 1st Bvd, 700506 Iasi, Romania.ORCID 0000-0003-4370-5353
Vasilichia AntociFaculty of Chemistry, Alexandru Ioan Cuza University of Iasi, 11 Carol 1st Bvd, 700506 Iasi, Romania.ORCID 0000-0003-1013-1293
Ionel I MangalagiuFaculty of Chemistry, Alexandru Ioan Cuza University of Iasi, 11 Carol 1st Bvd, 700506 Iasi, Romania.ORCID 0000-0002-4632-5076
Alexandru Ioan Cuza University · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study presents the synthesis, structural characterization, and in vitro evaluation of anticancer activity of some newly benzo[

Indexed as

Antineoplastic AgentsCarcinoma, Non-Small-Cell LungLung NeoplasmsMelanomaQuinolinesCell Line, TumorCell ProliferationDrug Screening Assays, AntitumorHumansMolecular StructureSaltsStructure-Activity RelationshipAntineoplastic AgentsQuinolinesSaltsanticancerbenzo[f]quinoline derivativescycloadductsquaternary salts

Identifiers

PMID37175832
PMCPMC10179047
OpenAlexW4367626808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.